<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="sub-topic" /><meta name="keywords" content="Carboplatin; Cisplatin; Oxaliplatin" /><meta name="IX" content="Carboplatin; Cisplatin; Oxaliplatin" /><title>Platinum compounds: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP5487-platinum-compounds.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP5487-platinum-compounds.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP5487-platinum-compounds.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 07 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP5179-malignant-disease-and-immunosuppression.htm">8 Malignant disease and immunosuppression</a> &gt; <a href="PHP5180-cytotoxic-drugs.htm">8.1 Cytotoxic drugs</a> &gt; <a href="PHP5425-other-antineoplastic-drugs.htm">8.1.5 Other antineoplastic drugs</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP5485-pentostatin.htm" title="Previous: PENTOSTATIN">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP5497-carboplatin.htm" title="Next: CARBOPLATIN">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a395017.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carboplatin</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Antineoplastic Agents 10:00</p></div></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a384036.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cisplatin</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Antineoplastic Agents 10:00</p></div></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a302033.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Oxaliplatin</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Antineoplastic Agents 10:00</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/16564-f.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Carboplatin</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: C &gt; Interactions of Carboplatin</p></div></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/1822-j.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Cisplatin</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: C &gt; Interactions of Cisplatin</p></div></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/2972-y.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Oxaliplatin</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: O &gt; Interactions of Oxaliplatin</p></div></li></ul><ul><li><h3>British National Formulary (6)</h3></li><li><a href="PHP5497-carboplatin.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">CARBOPLATIN</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs &gt; Platinum compounds</p></div></li><li><a href="PHP5498-carboplatin-non-proprietary.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carboplatin</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs &gt; Platinum compounds &gt; CARBOPLATIN</p></div></li><li><a href="PHP5499-cisplatin.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">CISPLATIN</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs &gt; Platinum compounds</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22carboplatin%22%22cisplatin%22%22oxaliplatin%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (6)</a></li></ul><ul><li><h3>BNF for Children (5)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13808-platinum-compounds.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Platinum compounds</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13809-carboplatin.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">CARBOPLATIN</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs &gt; Platinum compounds</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13810-carboplatin-non-proprietary.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carboplatin</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs &gt; Platinum compounds &gt; CARBOPLATIN</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22carboplatin%22%22cisplatin%22%22oxaliplatin%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (5)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/c-d1e255581.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cisplatin</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; C</p></div></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK1230.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Oxaliplatin</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; O</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a589006.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carboplatin</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; C</p></div></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a582041.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cisplatin</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; C</p></div></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a506013.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Oxaliplatin</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; O</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0003s0085.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carboplatin</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; C</p></div></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0003s0555.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cisplatin</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; C</p></div></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0014s0090.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Oxaliplatin</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; O</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/16564-f.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carboplatin</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antineoplastics &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/1822-j.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cisplatin</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antineoplastics &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/2972-y.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Oxaliplatin</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antineoplastics &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/01822.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carboplatin</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; C &gt; CA</p></div></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/02317.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cisplatin</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; C &gt; CI</p></div></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/06912.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Oxaliplatin</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; O &gt; OX</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy (8)</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/c4-sec1-002.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Locating Appropriate Types of Information Resources</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 1: The Science of Pharmacy &gt; Section 1: Introduction &gt; 4 Information Resources in Pharmacy and the Pharmaceutical Sciences</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/c5-sec1-0012.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Elements of Group VIII</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 1: The Science of Pharmacy &gt; Section 2: Pharmaceutical Chemistry &gt; 5 Inorganic Pharmaceutical Chemistry</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/c33-sec1-003.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Metal-Ion Coordination Complexes</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 1: The Science of Pharmacy &gt; Section 4: Pharmaceutics &gt; 33 Complex Formation</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22carboplatin%22%22cisplatin%22%22oxaliplatin%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (8)</a></li></ul><ul><li><h3>Stockley's Drug Interactions (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E32E3E0R0D705.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Carboplatin</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; C</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E14E3E0R0D575.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Cisplatin</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; C</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E2E3E0R0D1575.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Oxaliplatin</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; O</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>Platinum compounds</h1><?highlighter on?><div id="pC" class="jN"><p id="PHP5488"><strong>Carboplatin</strong> is widely used in the treatment of advanced ovarian cancer and lung cancer (particularly the small cell type). It is given <em>intravenously</em>. The dose of carboplatin is determined according to renal function rather than body surface area. Carboplatin can be given on an outpatient basis and is better tolerated than cisplatin; nausea and vomiting are reduced in severity and nephrotoxicity, neurotoxicity, and ototoxicity are much less of a problem than with cisplatin. It is, however, more myelosuppressive than cisplatin.</p> <p id="PHP5489"><strong>Cisplatin </strong> is used alone or in combination for the treatment of testicular, lung, cervical, bladder, head and neck, and ovarian cancer (but carboplatin is preferred for ovarian cancer). It is given <em>intravenously</em>. Cisplatin requires intensive intravenous hydration and treatment may be complicated by severe nausea and vomiting. Cisplatin is toxic, causing nephrotoxicity (monitoring of renal function is essential), ototoxicity, peripheral neuropathy, hypomagnesaemia and myelosuppression. It is, however, increasingly given in a day-care setting.</p> <p id="PHP5491"><strong>Oxaliplatin</strong> is licensed in combination with fluorouracil and folinic acid, for the treatment of metastatic colorectal cancer and as adjuvant treatment of colon cancer after resection of the primary tumour; it is given by intravenous infusion. Neurotoxic side-effects (including sensory peripheral neuropathy) are dose limiting. Other side-effects include gastro-intestinal disturbances, ototoxicity, and myelosuppression. If unexplained respiratory symptoms occur, oxaliplatin should be discontinued until investigations exclude interstitial lung disease and pulmonary fibrosis.</p> <div id="PHP5494" class="cI"><p class="cAE">NICE guidance</p><h3 class="cT">Irinotecan, oxaliplatin, and raltitrexed for advanced colorectal cancer (August 2005)</h3><p>A combination of fluorouracil and folinic acid with either irinotecan or oxaliplatin are options for first-line treatment for advanced colorectal cancer.</p><p>Irinotecan alone or fluorouracil and folinic acid with oxaliplatin are options for patients who require further treatment subsequently.</p><p>Raltitrexed is <strong>not</strong> recommended for the treatment of advanced colorectal cancer. Its use should be confined to clinical studies.</p></div> <div class="cI"><h3 class="cT">NICE guidance (capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes' C) colon cancer)</h3><p>See <a title="target-block: NICE guidance, Dukes C colon cancer" href="PHP5326-antimetabolites.htm#PHP5332">Antimetabolites</a></p></div> <div id="PHP5495" class="cI"><p class="cAE">NICE guidance</p><h3 class="cT">Paclitaxel for ovarian cancer (January 2003)</h3><p><em>Either</em> paclitaxel in combination with a platinum compound (cisplatin or carboplatin) <em>or</em> a platinum compound alone are alternatives for the first-line treatment of ovarian cancer (usually following surgery).</p></div> <div id="PHP5496" class="cI"><p class="cAE">NICE guidance</p><h3 class="cT">Paclitaxel, pegylated liposomal doxorubicin, and topotecan for second-line or subsequent treatment of advanced ovarian cancer (May 2005)</h3><p>Paclitaxel, combined with a platinum compound (carboplatin or cisplatin), is an option for advanced cancer that relapses 6 months or more after completing initial platinum-based chemotherapy. Paclitaxel alone is an option for advanced ovarian cancer that does not respond to, or relapses within 6 months of completing initial platinum-based chemotherapy.</p><p>Pegylated liposomal doxorubicin is an option for advanced ovarian cancer that does not respond to, or relapses within 12 months of completing initial platinum-based chemotherapy.</p><p>Paclitaxel alone or pegylated liposomal doxorubicin are options for advanced ovarian cancer in patients who are allergic to platinum compounds. Topotecan alone is an option only for advanced ovarian cancer that does not respond to, or relapses within 6 months of completing initial platinum-based chemotherapy or in those allergic to platinum compounds <em>and</em> for whom paclitaxel alone or pegylated liposomal doxorubicin are inappropriate.</p></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_PHP5497-carboplatin"><a href="PHP5497-carboplatin.htm" title="CARBOPLATIN">CARBOPLATIN</a></li><li id="_PHP5499-cisplatin"><a href="PHP5499-cisplatin.htm" title="CISPLATIN">CISPLATIN</a></li><li id="_PHP5501-oxaliplatin"><a href="PHP5501-oxaliplatin.htm" title="OXALIPLATIN">OXALIPLATIN</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP5485-pentostatin.htm">Previous: PENTOSTATIN</a> | <a class="top" href="PHP5487-platinum-compounds.htm#">Top</a> | <a accesskey="]" href="PHP5497-carboplatin.htm">Next: CARBOPLATIN</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>